Search research articles
Contact Us
Filters
Showing results (121-130 of 329) with videos related to
Page
of 33
Sort By:
Leukemia
|
November 2, 2007
Clinically relevant end points and new drug approvals for myeloma
K C Anderson, R A Kyle, S V Rajkumar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 8, 2001
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies
S P Treon, C Mitsiades, N Mitsiades, et al.
Blood
|
February 1, 1996
Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B
D Chauhan, H Uchiyama, Y Akbarali, et al.
Transfusion
|
January 1, 1996
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage
I Federowicz, B B Barrett, J W Andersen, et al.
Journal of Cellular Physiology
|
March 1, 1997
Activation signals regulate heat shock transcription factor 1 in human B lymphocytes
L Hardy, M Goodman, A Vasquez, et al.
Oncogene
|
August 14, 1997
Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
D Chauhan, P Pandey, A Ogata, et al.
Blood
|
December 1, 1992
Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans
K C Anderson, C Morimoto, S R Paul, et al.
Cancer Research
|
April 18, 2001
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells
T Hideshima, P Richardson, D Chauhan, et al.
Blood
|
August 26, 1998
Anti-estrogens induce apoptosis of multiple myeloma cells
S P Treon, G Teoh, M Urashima, et al.
Leukemia
|
November 7, 2017
Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
A Ray, D S Das, Y Song, et al.
Page
of 33
Search research articles
Search
Showing results (121-130 of 329) with videos related to
Sort By:
Page
of 33
Leukemia
|
November 2, 2007
Clinically relevant end points and new drug approvals for myeloma
K C Anderson, R A Kyle, S V Rajkumar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 8, 2001
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies
S P Treon, C Mitsiades, N Mitsiades, et al.
Blood
|
February 1, 1996
Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B
D Chauhan, H Uchiyama, Y Akbarali, et al.
Transfusion
|
January 1, 1996
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage
I Federowicz, B B Barrett, J W Andersen, et al.
Journal of Cellular Physiology
|
March 1, 1997
Activation signals regulate heat shock transcription factor 1 in human B lymphocytes
L Hardy, M Goodman, A Vasquez, et al.
Oncogene
|
August 14, 1997
Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
D Chauhan, P Pandey, A Ogata, et al.
Blood
|
December 1, 1992
Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans
K C Anderson, C Morimoto, S R Paul, et al.
Cancer Research
|
April 18, 2001
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells
T Hideshima, P Richardson, D Chauhan, et al.
Blood
|
August 26, 1998
Anti-estrogens induce apoptosis of multiple myeloma cells
S P Treon, G Teoh, M Urashima, et al.
Leukemia
|
November 7, 2017
Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
A Ray, D S Das, Y Song, et al.
Page
of 33